May 2020 Clinical Watch Newsletter

June 17, 2020

In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofibromas. Lastly, we review claims data to identify potential users for a new option to treat “off” episodes associated with Parkinson’s disease.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020

Next Article
Health disparities are front and center now. Where do we go from here?
Health disparities are front and center now. Where do we go from here?

Public health professionals have been sounding the alarm for years, but the COVID-19 pandemic and the sweep...